Variant report
Variant | nsv984244 |
---|---|
Chromosome Location | chr16:79892965-79894783 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr16:79890773..79893231-chr16:79899316..79902167,2 | K562 | blood: | |
2 | chr16:79891731..79895765-chr16:79895938..79901125,6 | K562 | blood: | |
3 | chr16:79891351..79893625-chr16:79919573..79921635,2 | MCF-7 | breast: | |
4 | chr16:79892054..79894771-chr16:79895938..79898564,3 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs575568925 | chr16:79892972-79892973 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs545896630 | chr16:79893003-79893004 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs377186900 | chr16:79893004-79893005 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs573031680 | chr16:79893015-79893016 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs77919279 | chr16:79893019-79893020 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs559080295 | chr16:79893024-79893025 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs546803672 | chr16:79893027-79893028 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs548434678 | chr16:79893036-79893037 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs149541581 | chr16:79893058-79893059 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs530510501 | chr16:79893061-79893062 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs374201438 | chr16:79893064-79893065 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs536281540 | chr16:79893087-79893088 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs146076662 | chr16:79893089-79893090 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs138910844 | chr16:79893121-79893122 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs193190201 | chr16:79893129-79893130 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs546728277 | chr16:79893144-79893145 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs142712569 | chr16:79893148-79893149 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs535694558 | chr16:79893177-79893178 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs557601117 | chr16:79893192-79893193 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs575883856 | chr16:79893196-79893197 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs539427998 | chr16:79893198-79893199 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs56086972 | chr16:79893206-79893207 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs78688838 | chr16:79893226-79893227 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs76432758 | chr16:79893239-79893240 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs147351255 | chr16:79893291-79893292 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs34742640 | chr16:79893308-79893309 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs541693016 | chr16:79893314-79893315 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs557935934 | chr16:79893316-79893317 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs183957555 | chr16:79893381-79893382 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs188739070 | chr16:79893383-79893384 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs111926238 | chr16:79893385-79893386 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs370530431 | chr16:79893405-79893406 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs61176300 | chr16:79893408-79893409 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs35993458 | chr16:79893409-79893410 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs533473626 | chr16:79893415-79893416 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs139600174 | chr16:79893416-79893417 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs564031577 | chr16:79893428-79893429 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs376012254 | chr16:79893438-79893439 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs13332408 | chr16:79893440-79893441 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs540544490 | chr16:79893448-79893449 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs546691205 | chr16:79893463-79893464 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs551531069 | chr16:79893505-79893506 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs568081238 | chr16:79893548-79893549 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs529477276 | chr16:79893591-79893592 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs550924218 | chr16:79893602-79893603 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs181218713 | chr16:79893603-79893604 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs539701793 | chr16:79893609-79893610 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs558031750 | chr16:79893627-79893628 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs566497723 | chr16:79893630-79893631 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs141660940 | chr16:79893641-79893642 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Schizophrenia | 22958593 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Prostate cancer | 18632612 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16702952 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Prostate cancer | 19242612 | CNVD |
Cancer | 22429812 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Melanoma | 18172304 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 17001317 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17603634 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 17245344 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Breast cancer | 21806811 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Lung cancer | 18438408 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Adrenocortical carcinoma | 18281524 | CNVD |
Neurocytoma | 17123091 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Hypoplastic left heart syndrome | 22349727 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Autism | 21865298 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr16:79892800-79894600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
2 | chr16:79893000-79893200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
3 | chr16:79893000-79894000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
4 | chr16:79893000-79894200 | Enhancers | Primary hematopoietic stem cells | blood |
5 | chr16:79893000-79894600 | Enhancers | Fetal Thymus | thymus |
6 | chr16:79893200-79893400 | Enhancers | Esophagus | oesophagus |
7 | chr16:79893200-79893400 | Enhancers | GM12878-XiMat | blood |
8 | chr16:79893200-79893800 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
9 | chr16:79893200-79893800 | Enhancers | Fetal Lung | lung |
10 | chr16:79893400-79894000 | Weak transcription | GM12878-XiMat | blood |
11 | chr16:79893800-79894600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
12 | chr16:79894000-79894200 | Enhancers | Esophagus | oesophagus |
13 | chr16:79894000-79894200 | Enhancers | GM12878-XiMat | blood |
14 | chr16:79894200-79896400 | Weak transcription | Primary hematopoietic stem cells | blood |
15 | chr16:79894200-79897400 | Weak transcription | GM12878-XiMat | blood |
16 | chr16:79894600-79896600 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
17 | chr16:79894600-79896600 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
18 | chr16:79894600-79896600 | Weak transcription | Fetal Thymus | thymus |